As measles spreads, old vaccination canards do too
For as long as there have been vaccines, there has been passionate opposition to them
For as long as there have been vaccines, there has been passionate opposition to them

Immunisation has helped cut global cases by 71% since 2000 but progress is slowing

The decline in funding for vaccinations poses a worldwide threat

2025 has been a good year for immunisation science, but not in the US

Vaccine businesses seen as valuable parts of pharma groups but government hostility could deter future developments

Recent setbacks for the movement signal a potential turning point for the vaccine makers as the market picks up

With the NHS in triage mode, business and society need to shift to prevention of ill health